Using diosmin to help treat non-bleeding peptic ulcers
Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer
This study is testing if adding diosmin to the usual treatment can help people aged 25 to 65 with non-bleeding peptic ulcers heal better and feel better.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 44 (estimated) |
| Ages | 25 Years to 65 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, El Gharbia) |
| Trial ID | NCT05670457 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety and effectiveness of diosmin as an additional treatment for patients suffering from non-bleeding peptic ulcers. Participants aged 25 to 65, diagnosed with either duodenal or gastric ulcers through endoscopy, will receive diosmin alongside standard care. The study aims to determine if diosmin can enhance healing and improve patient outcomes in this specific condition.
Who should consider this trial
Good fit: Ideal candidates are adults aged 25-65 with a diagnosis of non-bleeding peptic ulcers confirmed by endoscopy.
Not a fit: Patients with other causes of gastric bleeding, cancer, liver disease, or those who have undergone bariatric surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a new option for patients with non-bleeding peptic ulcers, potentially improving healing rates and reducing complications.
How similar studies have performed: While the use of diosmin in this context is being evaluated, similar studies on adjuvant therapies for peptic ulcers have shown promise, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: -. Age 25-65 years old. * Patients of both gender (male and female). * Non-bleeding Peptic ulcer Patients (duodenal \&gastric) diagnosed by endoscopy. Exclusion Criteria: * The presence of other factors that can lead to gastric bleeding other than peptic ulcer. * Patients with cancerous disease * Breast-feeding. * Surgically altered stomach ( bariatric surgery), * Patient with liver disease. * Bleeding \& perforated peptic ulcer.
Where this trial is running
Tanta, El Gharbia
- Tanta University — Tanta, El Gharbia, Egypt (Recruiting)
Study contacts
- Study coordinator: Ahmed G Abdelfatah
- Email: ahmed131692@pharm.tanta.edu.eg
- Phone: 201017458534
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.